Latest filing published 15 Aug 2022 for Panacea Life Sciences Holdings, INC., €620.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +160.8%Entry US$0.09 · Close at T+365 US$0.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Lawrence Wert: trading record in brief
Filings by Lawrence Wert span 2 companies, the busiest being Tribune Media Co and Panacea Life Sciences Holdings, Inc. We count 43 filings; the first trade dates from 1 January 2015 and the latest from 11 August 2022.
Purchases make up the whole of the open-market record (3 purchases, €1,900). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 25 share grants and 14 option exercises. Since January 2022: 3 purchases and no sales on the market.
A typical purchase (the median) is worth €625. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 3 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +3.2%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 15 August 2022, reports an open-market purchase of €620 in Panacea Life Sciences Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lawrence Wert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$0.12832.7% of flowCommon StockSEC:0001493152-22-022609:1Canonical exit: 9 Nov 2022 (T+90)
- 5,000 shares@ US$0.13534.4% of flowCommon StockSEC:0001493152-22-022609:2Canonical exit: 9 Nov 2022 (T+90)
- 5,000 shares@ US$0.129100.0% of flowCommon StockSEC:0001493152-22-022609:0Canonical exit: 9 Nov 2022 (T+90)
- 3,500,000 shares0Common StockSEC:0001415889-21-003532:1
- 28,000,000 shares0Common StockSEC:0001415889-21-003532:2
- 65,789 shares0Common StockSEC:0001415889-21-003532:0
- 57,113 shares@ US$46.6990.4% of flowClass A Common StockSEC:0001209191-19-050330:0
- 14,089 shares0Class A Common StockSEC:0001209191-19-016947:0
- 4,128 shares@ US$46.426.2% of flowClass A Common StockSEC:0001209191-19-016947:1
- 614 shares@ US$46.290.9% of flowClass A Common StockSEC:0001209191-19-011052:1
- 2,096 sharesClass A Common StockSEC:0001209191-19-011052:0
- 384 shares@ US$46.070.6% of flowClass A Common StockSEC:0001209191-19-009710:1
- 1,311 sharesClass A Common StockSEC:0001209191-19-009710:0
- 668 shares@ US$46.101.0% of flowClass A Common StockSEC:0001209191-19-009274:1
- 2,312 sharesClass A Common StockSEC:0001209191-19-009274:0
- 1,525 sharesClass A Common StockSEC:0001209191-19-007312:0
- 528 shares@ US$45.970.8% of flowClass A Common StockSEC:0001209191-19-007312:1
- 5,336 shares0Class A Common StockSEC:0001209191-18-017500:0
- 1,500 shares@ US$42.061.7% of flowClass A Common StockSEC:0001209191-18-017500:1
- 2,044 sharesClass A Common StockSEC:0001209191-18-010930:0
- 575 shares@ US$42.630.6% of flowClass A Common StockSEC:0001209191-18-010930:1
- 2,447 sharesClass A Common StockSEC:0001209191-18-009714:0
- 686 shares@ US$42.190.8% of flowClass A Common StockSEC:0001209191-18-009714:1
- 2,254 shares0Class A Common StockSEC:0001209191-18-009255:0
- 658 shares@ US$42.140.7% of flowClass A Common StockSEC:0001209191-18-009255:1
25 of 43 declarations
